These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17525630)

  • 21. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.
    Vanguri VK; Woda BA; Jiang Z
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):365-8. PubMed ID: 16932031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMACR expression in colorectal cancer is associated with left-sided tumor localization.
    Marx A; Simon P; Simon R; Mirlacher M; Izbicki JR; Yekebas E; Kaifi JT; Terracciano L; Sauter G
    Virchows Arch; 2008 Sep; 453(3):243-8. PubMed ID: 18712414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Methylacyl-CoA racemase (P504S) is a useful marker for the differential diagnosis of solid pseudopapillary neoplasm of the pancreas.
    Shen Y; Wang Z; Zhu J; Chen Y; Gu W; Liu Q
    Ann Diagn Pathol; 2014 Jun; 18(3):146-50. PubMed ID: 24675392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-methylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes.
    Guzman G; Wu SJ; Kajdacsy-Balla A; Cotler SJ
    Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):411-6. PubMed ID: 17122637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
    Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.
    Nassar A; Amin MB; Sexton DG; Cohen C
    Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):252-5. PubMed ID: 16082251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy.
    Jiang Z; Woda BA
    Adv Anat Pathol; 2004 Nov; 11(6):316-21. PubMed ID: 15505533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival.
    Mroz A; Kiedrowski M; Lewandowski Z
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):313-7. PubMed ID: 23235347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation.
    Kuefer R; Varambally S; Zhou M; Lucas PC; Loeffler M; Wolter H; Mattfeldt T; Hautmann RE; Gschwend JE; Barrette TR; Dunn RL; Chinnaiyan AM; Rubin MA
    Am J Pathol; 2002 Sep; 161(3):841-8. PubMed ID: 12213712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of role of alpha-methyl acyl-coenzyme A racemase/P504S and high molecular weight cytokeratin in diagnosing prostatic lesions.
    Jain D; Gupta S; Marwah N; Kalra R; Gupta V; Gill M; Jain N; Lal S; Sen R
    J Cancer Res Ther; 2017; 13(1):21-25. PubMed ID: 28508828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus.
    Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
    Histopathology; 2013 Nov; 63(5):630-9. PubMed ID: 24004067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer.
    Gunia S; May M; Scholmann K; Störkel S; Hoschke B; Koch S; Dietel M; Kristiansen G
    Virchows Arch; 2008 Aug; 453(2):165-70. PubMed ID: 18648853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant melanomas from dysplastic nevi and melanocytic nevi.
    Abbas M; Ploch EM; Wehling J; Schipper E; Janciauskiene S; Kreipe HH; Jonigk D
    Tumour Biol; 2014 Dec; 35(12):12015-20. PubMed ID: 25149154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
    Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.
    Lakis S; Papamitsou T; Panagiotopoulou C; Kotakidou R; Kotoula V
    World J Gastroenterol; 2010 May; 16(20):2476-83. PubMed ID: 20503447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation.
    Gatalica Z; Stafford P; Vranic S
    Hum Pathol; 2022 Nov; 129():40-46. PubMed ID: 35998819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry in Barrett's and colorectal mucosa: only significant overexpression favours a diagnosis of intraepithelial neoplasia.
    Sträter J; Wiesmüller C; Perner S; Kuefer R; Möller P
    Histopathology; 2008 Feb; 52(3):399-402. PubMed ID: 18081815
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.
    Li W; Cagle PT; Botero RC; Liang JJ; Zhang Z; Tan D
    J Exp Clin Cancer Res; 2008 May; 27(1):2. PubMed ID: 18577240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
    Witkiewicz AK; Varambally S; Shen R; Mehra R; Sabel MS; Ghosh D; Chinnaiyan AM; Rubin MA; Kleer CG
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1418-23. PubMed ID: 15941950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.